logo
Twitter
Discord
Email
logo
Owlet, Inc.

Owlet, Inc.

NYSE•OWLT
CEO: Mr. Kurt Workman
Sector: Healthcare
Industry: Medical - Devices
Listing Date: 2020-11-05
Owlet, Inc. provides digital parenting solutions in the United States and internationally. The company's platform focuses on giving real-time data and insights to parents. It offers Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology to track vitals signs, such as pulse rate, activity, oxygen, and sleep patterns; BabySat which is intended for infants with heightened health risk; Owlet Cam, a monitoring device in smartphones that offers video and audio, predictive sleep insights, and cry detections; and accessories, including Owlet Sleeper, as well as Duo and Dream Duo that combines Smart Sock with the Owlet Cam. The company was founded in 2012 and is headquartered in Lehi, Utah.
Contact Information
3300 North Ashton Boulevard, Suite 300, Lehi, UT, 84043, United States
844-334-5330
www.owletcare.com
Market Cap
$207.54M
P/E (TTM)
-5.3
37.1
Dividend Yield
--
52W High
$16.94
52W Low
$2.75
52W Range
72%
Rank63Top 94.0%
1.8
F-Score
Modified Piotroski Analysis
Based on 6-year fundamentals
Weak • 1.8 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2020-2025

Financial Dashboard

Q3 2025 Data

Revenue

$31.99M+44.60%
4-Quarter Trend

EPS

$0.17-127.87%
4-Quarter Trend

FCF

-$2.43M-71.33%
4-Quarter Trend

2025 Q3 Earnings Highlights

Key Highlights

Revenue Growth Strong Revenues $79.16M, up 37.5% (9M 2025). Driven by Dream Sock/Duo sales growth and new subscription.
Gross Margin Expansion Noted Gross Margin 51.7% (9M 2025), improving 2.5 points. Favorable product mix offset tariff cost pressures.
Operating Loss Significantly Reduced Operating loss narrowed to $(3.37M) (9M 2025). Significant improvement from $(12.81M) loss in prior period.
Cash Position Maintained Cash reserves $23.76M end of period. Financing provided $14.22M net cash inflow for nine months.

Risk Factors

Going Concern Doubt Remains Historical losses and negative operating cash flow ($10.34M used 9M 2025) raise substantial doubt about viability.
Internal Control Deficiencies Noted Material weaknesses identified in control environment, personnel staffing, and segregation of journal entry duties.
Warrant Liability Volatility Impact Adjustment caused $23.80M loss for nine months ended September 30, 2025, significantly widening net loss.
Product Sourcing Tariff Exposure Vietnam/Thailand sourcing faces 19%-40% tariffs, potentially pressuring COGS and overall profitability metrics.

Outlook

Recent Equity Financing Secured Completed October 2025 offering, raising $32.11M net proceeds for commercialization and R&D support efforts.
Debt Facilities Heavily Utilized ABL Line of Credit drew $18.62M; WTI Loan Facility holds $7.50M principal outstanding as of September 30, 2025.
Subscription Revenue Growing Owlet360 service launched January 2025, now contributing a growing minority portion of total revenues.
Major Litigation Settled Company paid $5.25M total liability for securities litigation during the third quarter of 2025, resolving claims.

Peer Comparison

Revenue (TTM)

Lucid Diagnostics Inc.LUCD
$1.21B
+28885.2%
Owlet, Inc.OWLT
$99.66M
+26.8%
Sight Sciences, Inc.SGHT
$76.05M
-4.4%

Gross Margin (Latest Quarter)

Sight Sciences, Inc.SGHT
86.4%
+2.5pp
TriSalus Life Sciences, Inc.TLSI
83.5%
-2.8pp
AVITA Medical, Inc.RCEL
81.3%
-2.4pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
SGHT$318.29M-6.8-61.6%35.0%
PROF$240.41M-6.0-86.8%0.7%
OWLT$207.54M-5.3126.8%33.3%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
16.0%
Strong Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
25%
Cash Flow Needs Attention

Research & Insights

Next earnings:Mar 3, 2026
|
EPS:-$0.13
|
Revenue:-
Reports
All Years

  • Form 10-Q - Q3 2025

    Period End: Sep 30, 2025|Filed: Nov 13, 2025|
    Revenue: $31.99M+44.6%
    |
    EPS: $0.17-127.9%
    Beat

  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Aug 8, 2025|
    Revenue: $26.06M+25.9%
    |
    EPS: $-2.37+690.0%
    Miss

  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: May 8, 2025|
    Revenue: $21.10M+43.1%
    |
    EPS: $0.11-26.7%
    Beat

  • Form 10-K/A - FY 2024

    Period End: Dec 31, 2024|Filed: Apr 30, 2025|
    Revenue: $78.06M+44.5%
    |
    EPS: $-0.83+81.7%
    Miss

  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Mar 11, 2025|Refer to amended data

  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Nov 14, 2024|
    Revenue: $22.12M+140.9%
    |
    EPS: $-0.61-27.4%
    Miss

  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Aug 14, 2024|
    Revenue: $20.70M+58.2%
    |
    EPS: $-0.30-70.9%
    Miss

  • Form 10-Q - Q1 2024

    Period End: Mar 31, 2024|Filed: May 13, 2024|
    Revenue: $14.75M+37.9%
    |
    EPS: $0.15-109.7%
    Meet